Qatar World Cup 2022Portugal beats Uruguay 2-0, qualifies for round of 16

Zydus gets USFDA approval for generic drug

The drug is used to treat high blood pressure in the lungs

October 01, 2022 10:47 am | Updated 10:47 am IST - New Delhi

A view of the Zydus Cadila laboratory. Photo used for representation purpose only.

A view of the Zydus Cadila laboratory. Photo used for representation purpose only. | Photo Credit: Special Arrangement

Zydus Lifesciences on Saturday said it has received approval from the U.S. health regulator to market Sildenafil for oral suspension, used to treat pulmonary hypertension, in the American market.

The company has received approval from the U.S. Food and Drug Administration (USFDA) to market the product, the drug maker said in a statement.

Sildenafil for oral suspension is used to treat high blood pressure in the lungs (pulmonary hypertension). It works by relaxing and widening the blood vessels in lungs which allows the blood to flow more easily.

Decreasing high blood pressure in the lungs allows the heart and lungs to work better and improves the ability to exercise.

Zydus said the drug will be manufactured at its Baddi-based manufacturing plant.

As per IQVIA data, Sildenafil for oral suspension had annual sales of $65 million in the U.S.

Top News Today

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.